AstraZeneca vows to spend US$50 billion on US manufacturing, development
The investment will go towards manufacturing as well as research and development, Astra said in a statement. It includes US$4 billion for a new facility in Virginia that will make drugs for chronic diseases, Kevin Hassett, director of the US National Economic Council, said on Monday (Jul 21) at an event in Washington, DC.
'With the completion of this investment, substantially all of AstraZeneca's pharmaceuticals sold at the United States will be produced in the United States,' Hassett said.
Astra's announcement comes as European drug companies rush to highlight their significant footprints in the US in hopes of mitigating the impact of any potential tariffs from US President Donald Trump. Astra already announced plans in November, a week after Trump's election, to invest US$3.5 billion in the US by the end of 2026, noting at the time that it employs nearly 18,000 people in the country.
Since then, European competitors have touted even larger spending plans. Switzerland's Novartis in April announced plans for US$23 billion in US-based infrastructure spending, while cross-town rival Roche Holding said it would invest US$50 billion. In May, French drugmaker Sanofi announced intent to invest at least US$20 billion in the US by 2030.
Pascal Soriot, who's been chief executive officer of Astra since 2012, has also urged tariff restraint. This spring, he recommended that US officials exempt medicines from tariffs, arguing that tax incentives are a better way to attract investment in drug development and manufacturing.
BT in your inbox
Start and end each day with the latest news stories and analyses delivered straight to your inbox.
Sign Up
Sign Up
Trump has proposed various timelines for tariffs on pharmaceuticals, most recently floating duties that would be imposed as soon as Aug 1. The president said that he expects to give companies a year to bring manufacturing to the US before imposing tariffs as high as 200 per cent.
Meanwhile, Soriot has raised concerns in the UK about his commitment to the home country. He has long complained about the UK's regulatory environment, which he says is a threat to hold back the UK from staying competitive with the US and China.
In January, Astra abandoned plans for a £450 million (S$777 million) vaccine manufacturing plant in Liverpool. The company operates 17 manufacturing sites in 12 US states.
Earlier this month, British paper The Times reported that Soriot is considering moving the company's stock listing to the US. That would be a major blow to the UK's equity markets, which have endured similar defections from other companies in recent years.
Under Soriot's leadership, Astra's market value has more than tripled as the company has become a global powerhouse in cancer medicines. It's also built up a significant drug pipeline for other areas including cardiovascular, renal and metabolic diseases. BLOOMBERG
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Straits Times
6 minutes ago
- Straits Times
Malaysia cuts growth forecast on tariff volatility
Bank Negara Malaysia now sees the economy expanding by 4 per cent to 4.8 per cent, lower than its previous forecast of 4.5 per cent to 5.5 per cent. KUALA LUMPUR - Malaysia's central bank lowered its growth projection for 2025 as it contends with the fallout from US President Donald Trump's tariffs. Bank Negara Malaysia now sees the economy expanding within the range of 4 per cent to 4.8 per cent, lower than its previous forecast of 4.5 per cent to 5.5 per cent. It also trimmed its inflation forecast this year to 1.5 per cent to 2.3 per cent, from 2 per cent to 3.5 per cent, amid a moderation in cost and demand outlook. 'The updated growth projections account for various tariff scenarios, ranging from a continued elevation of tariffs to more favourable trade negotiation outcomes,' Bank Negara said in a statement on July 28. 'This forecast remains subject to uncertainties surrounding the global economy, both on the downside and upside.' Favourable trade negotiation outcomes, pro-growth policies in major economies, continued demand for electrical and electronic goods, and robust tourism activity could raise Malaysia's export and growth prospects, it added. The revised forecast comes as Malaysia seeks to lower US tariffs to less than 20 per cent, after Mr Trump increased a threatened levy on the South-east Asian country to 25 per cent. The country has until Aug 1 to conclude negotiations, and is optimistic of reaching a deal. Bank Negara said Malaysia is facing external headwinds from a position of strength, pointing to resilience in the economy based on advanced estimates in the second quarter. Domestic demand will continue to support growth going forward, it said. Top stories Swipe. Select. Stay informed. Singapore Tanjong Katong sinkhole backfilled; road to be repaved after LTA tests Singapore MRT platform screen doors at 15 underground stations to undergo renewal Singapore 'Medium risk' of severe haze as higher agricultural prices drive deforestation: S'pore researchers Singapore Jail for former pre-school teacher who tripped toddler repeatedly, causing child to bleed from nose Singapore Police statements by doctor in fake vaccine case involving Iris Koh allowed in court: Judge Singapore Authorities say access to Changi intertidal areas unaffected by reclamation, in response to petition Singapore SMRT reports unauthorised post on its X account, says investigation under way Singapore No change to SIA flights between S'pore and Cambodia, S'pore and Thailand, amid border dispute Inflationary pressure from global commodity prices is expected to remain limited, contributing to moderate domestic cost conditions, the central bank said. The impact of local policy measures is also likely to remain contained, it added. BLOOMBERG
Straits Times
6 minutes ago
- Straits Times
Airwallex launches investment product to help businesses grow idle cash
Find out what's new on ST website and app. The new Airwallex Yield product is aimed at small business customers or customers on Airwallex. SINGAPORE - Fintech firm Airwallex has unveiled a new investment product aimed at helping businesses earn returns on unused funds, entering a competitive market where rivals also court companies seeking better yields on spare cash. Rolled out on July 28, the product invests in money market funds (MMFs) and offers returns of up to 1.29 per cent per annum for Singapore-dollar funds and up to 3.84 per cent for US-dollar funds. The new Airwallex Yield product is aimed at small business customers or customers on Airwallex, said Mr Arnold Chan, Airwallex's general manager for Asia-Pacific excluding China. 'Airwallex Yield will allow businesses to earn returns on their surplus Singapore-dollar and US-dollar funds by investing through investment-grade money market funds, while maintaining access to both liquidity and control over their cash,' he told The Straits Times. A MMF invests in a range of liquid, low-risk assets, which typically include cash and short-term instruments such as treasury bills, commercial paper, and certificates of deposit. Airwallex's yield product invests in several Goldman Sachs and Fullerton funds. The Singapore launch follows earlier rollouts in Australia and Hong Kong. Since its November 2023 debut in Australia, the product has attracted about US$200 million (S$256 million) in funds. Airwallex offers a suite of financial products for businesses, including global business accounts, cross-border payments and expense management tools. The firm said it is seeing a huge demand from customers in Singapore who want to earn returns while maintaining flexibility to move funds quickly. Over 80 per cent of its annual revenue comes from customers who use more than one Airwallex service and the firm expects to cross-sell the new product to its existing customers. The firm also plans to target technology companies, especially those backed by venture capital and holding substantial idle cash reserves, as well as e-commerce players and retailers that receive customer payments upfront but pay suppliers later. By investing these interim funds, they can generate additional returns. Trading businesses involved in importing and exporting can also benefit by putting their idle cash or working capital to work, said Mr Chan. He added that withdrawals are flexible and settlement is typically completed within one business day, provided that cut-off times were met. Airwallex joins a competitive field in Singapore, where firms like StashAway and Syfe already offer MMF products to businesses seeking returns on idle cash with flexible access. Most MMFs in Singapore invest in fixed deposits, government securities and commercial papers. Airwallex customer GlobalTix, a ticketing software and distribution platform for the tourism sector, said that it considers flexibility, liquidity, tenure and yield as key factors when deciding how to deploy idle cash. GlobalTix's co-founder and chief operating officer Chan Chee Kong said fixed deposits are less suitable for the company because they tie up funds for a set period – limiting access when quick payments to suppliers or vendors are needed. 'I need to have that flexibility around moving my funds in and out,' he said. Another key consideration is managing different currencies given the global nature of the firm's business, he added. He noted that Airwallex is not the first to offer the solution, adding that GlobalTix currently uses a similar offering from a competitor. However, if GlobalTix were to use Airwallex's new offering, it would benefit from having all its financial tools on a single platform – making it easier to monitor and manage its cash flow, he said. Lovet, a homegrown fashion brand and Airwallex customer, is considering the new yield product, its director Lee Wei Leong said. With interest rates declining, he said the company is exploring options. 'If we leave our money in a normal savings account, the value of the money is going to be eroded by inflation.' As an SME without venture capital backing, liquidity is key. If Lovet were to open a new outlet, it will need to be able to cash out quickly to fund the expansion, he added.
Business Times
6 minutes ago
- Business Times
Defiant Fed chief to send clear signal he calls the shots on US monetary policy
[WASHINGTON] US President Donald Trump has gone to extraordinary lengths to pressure US Federal Reserve chairman Jerome Powell to cut interest rates, but Trump's decision to feud with the central banker is having the opposite of its intended effect. Anyone who watched the both of them during Trump's tour of the Fed's building renovation project on Thursday (Jul 24) could easily tell that the two are on a collision course. Powell, however, remains unbowed. Rather than being defensive when Trump confronted him about the budget overrun of the renovation, Powell instead corrected Trump on his cost estimates. Trump is bound to keep berating Powell until his term ends in May 2026, and Powell is very unlikely to cut rates any time soon. As the central bank's Federal Open Market Committee prepares to meet this week, Wall Street economists are expecting the benchmark rate to stay in a range of between 4.25 and 4.5 per cent for the fifth straight meeting. Markets are likely to await Powell's press conference on Wednesday to gauge whether this is a 'dovish' hold, where the rate-setting committee leans towards a rate cut as the next move, or a 'hawkish' hold, where the committee is becoming more concerned about inflation. One brokerage said that Powell will likely keep his cards close to his chest. BT in your inbox Start and end each day with the latest news stories and analyses delivered straight to your inbox. Sign Up Sign Up 'We expect the Fed to maintain maximal optionality at its July meeting,' said economists at Bank of America Global Research, in a note to clients. 'Powell would prefer to see the July data before potentially guiding the markets for September at (the Fed's annual economic symposium in) Jackson Hole.' The economists added that 'markets will be focused on whether Powell underscores the Fed's desire to cut rates this year, or if he remains non-committal'. Nonetheless, Powell could give a hawkish signal if he emphasises the continued threat of tariffs, or a dovish one 'if he focuses on the stability of services inflation and expectations'. In the second-quarter earnings season, most companies – with rare exceptions such as German automaker Volkswagen, which is heavily dependent on US exports – seem to be taking tariffs in their stride. Of course, that could simply mean that US households are bearing more of the pain as corporations successfully pass on the costs of new tariffs. While Trump appears to have succeeded in forcing a new protectionist trade regime on the world without the kind of market meltdown that seemed imminent in the aftermath of his 'Liberation Day' in April, the Fed and other economists still view short-term or even long-term consumer-price increases as a likely result. At his press conference this Wednesday, Powell is likely to flex the Fed's muscle as an independent agency. Any sign that he was bowing to Trump's pressure campaign would represent more than reputational damage. The Fed has the ability to act as the backstop of the US Treasury market and only as long as market participants trust the central bank to police inflation. If markets sniffed out signs that the Fed had shifted its mission to a fiscal one – concentrating solely on economic stimulus, as Trump seems to be advocating, and as less influential central banks elsewhere often do – the Treasury market would simply cease responding to the Fed. This happened in the 1970s, when inflation was out of control. In those years, Treasury yields, and hence mortgage rates and other consumer loans, spiked above 10 per cent. 'We think Trump's pressure on the Fed to cut rates makes rate cuts less likely,' said strategists at BNP Paribas. The pressure campaign has made Treasury markets jumpy, however, because of fears about the role of politics at the Fed, they said. Powell pushed back on Trump's esimates of renovation costs on Thursday's tour of the Fed building. This week, he's likely to push back again to remind global markets – and more importantly, Trump – who calls the shots on US monetary policy.
